This page shows the latest Oxford Nanopore news and features for those working in and with pharma, biotech and healthcare.
and laboratories from next week, and will be supplied by Oxford Nanopore. ... chief executive officer of Oxford Nanopore.
Big biopharma investment good news for gene sequencing company. Amgen has taken a £50m ($66m) minority stake in Oxford Nanopore Technologies (ONT), a UK company making waves in the genetic sequencing ... Gordon Sanghera. It’s the second fundraising
The company said last year that lower-cost sequencing technology from firms such as Life Technologies and Oxford Nanopore Technologies could eventually knock Illumina off the top of the gene sequencing
More from news
Approximately 2 fully matching, plus 1 partially matching documents found.
UK-based sequencing company Oxford Nanopore Technologies is a leader in software- defined instruments, deploying a new generation of DNA sequencing technology across an electronics- based platform. ... To power the next generation of PromethION, Oxford
New funds such as Oxford Sciences Innovation, Syncona (which listed at the start of the year and consequently increased its deployment capital) are likely to reinforce this trend going forward. ... It is of course too early to speculate on the life
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
No results were found
Established in 2001, Fishawack Health (FH) is a purposefully built commercialization partner for the biopharmaceutical, medical technology, and wellness industries....